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Abstract
Background: Patients undergoing heart surgery continue to be the largest demand on blood transfusions. The
need for transfusion is based on the risk of complications due to poor cell oxygenation, however large transfusions
are associated with increased morbidity and risk of mortality in heart surgery patients. The aim of this study was to
identify preoperative and intraoperative risk factors for transfusion and create a reliable model for planning
transfusion quantities in heart surgery procedures.
Methods: We performed an observational study on 3315 consecutive patients who underwent cardiac surgery
between January 2000 and December 2007. To estimate the number of packs of red blood cells (PRBC) transfused
during heart surgery, we developed a multivariate regression model with discrete coefficients by selecting dummy
variables as regressors in a stepwise manner. Model performance was assessed statistically by splitting cases into
training and testing sets of the same size, and clinically by investigating the clinical course details of about one
quarter of the patients in whom the difference between model estimates and actual number of PRBC transfused
was higher than the root mean squared error.
Results: Ten preoperative and intraoperative dichotomous variables were entered in the model. Approximating the
regression coefficients to the nearest half unit, each dummy regressor equal to one gave a number of half PRBC.
The model assigned 4 units for kidney failure requiring preoperative dialysis, 2.5 units for cardiogenic shock, 2 units
for minimum hematocrit at cardiopulmonary bypass less than or equal to 20%, 1.5 units for emergency operation,
1 unit for preoperative hematocrit less than or equal to 40%, cardiopulmonary bypass time greater than 130
minutes and type of surgery different from isolated artery bypass grafting, and 0.5 units for urgent operation, age
over 70 years and systemic arterial hypertension.
Conclusions: The regression model proved reliable for quantitative planning of number of PRBC in patients
undergoing heart surgery. Besides enabling more rational resource allocation of costly blood-conservation
strategies and blood bank resources, the results indicated a strong association between some essential
postoperative variables and differences between the model estimate and the actual number of packs transfused.
Background
Despite published blood conservation and transfusion
guidelines, transfusion practices in heart-surgery patients
differ widely between physicians and institutions. For
example, in Europe, packs of red blood cells (PRBC) are
transfused in about half of all patients undergoing heart
surgery, but their use varies from 8% to 90% depending
on the institution [1]. A minority of patients (from 15%
to 20%) need more than 80% of the blood products
transfused during the operation [2].
Although blood transfusion is an essential therapy
during surgical procedures, better quantification and
limitation of the need for transfusions may improve
clinical outcome [3]. It is difficult to define the advan-
tages of blood transfusion, but enhanced oxygen-carry-
ing capacity, improved hemostasis and cardiac function
volume support are three important aspects [4,5]. How-
ever transfusion of blood packs has been more and
more recognized as a risk factor for adverse outcome
after heart surgery and unnecessary transfusions have
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indirect hospitalization costs [6]. The Task Force on
Blood Component Therapy of the American Society of
Anesthesiologists developed a consensus statement sug-
gesting that “red blood cell transfusions should not be
dictated by a single hemoglobin trigger but instead
should be based on the patient’s risk of developing com-
plications of inadequate oxygenation” [7].
Previous studies aimed at identifying a set of preo-
perative variables associated with need for blood trans-
fusion in heart surgery patients [8-11]. In particular,
Alghamdi and co-workers used a logistic regression
approach to define an index based on eight preoperative
variables [9]. The index was called Transfusion Risk
Understanding Scoring Tool (TRUST). Karkouti and co-
workers analysed data from heart surgery patients at
seven Canadian hospitals to determine interhospital var-
iation and predictability of large-volume transfusions
[10]. They found interhospital variation that could not
be explained by patient - or surgery-related factors.
Ranucci and co-workers proposed a simple score,
named Transfusion Risk and Clinical Knowledge
(TRACK) [11]. This score only uses five preoperative
variables to predict transfusion rate in heart surgery.
Despite remarkable differences in transfusion practices
and heart surgery procedures, these studies confirm the
interest in developing protocols of blood conservation
based on quantitative models obtained from available
evidence.
Analysing a set of preoperative and intraoperative
variables associated with transfusions in patients under-
going isolated coronary artery bypass grafting (CABG),
isolated valve, or combined procedures (CABG plus
v a l v e ) ,w ep r o p o s eas i m p l em o d e l ,w h i c hd o e sn o t
require computers, to estimate the need for PRBC of
new cases in clinical practice. This tool may help in the
management of critical patients, when much time and
attention is dedicated to medical and pharmacological
care, because blood conservation can be most produc-
tive for high-risk subjects. The clinical course of patients
showing the highest differences between actual and
model-estimated number of blood packs was also ana-
lyzed for potential model weaknesses and to understand
the reasons for significant discrepancies between model
estimates and medical decisions.
Methods
Patient set and acquired variables
For the present observational study, 3315 consecutive
patients between January 2000 and December 2007 were
entered in a prospectively collected database and ana-
lyzed retrospectively. They underwent isolated CABG,
single valve, or combined procedures at the Cardiac Sur-
gery Unit of “Santa Maria alle Scotte” University
Hospital, Siena, Italy. Exclusion criteria included age less
than 18 years, operation without cardiopulmonary
bypass (CPB), heart or heart-lung transplant and aortic
dissection. Patients were assigned at random to two sets
of equal size: a training set used to design the model
and a testing set used to verify model performance on
new data.
Data was obtained from the hospital database by
retrieving baseline demographic and clinical information
collected prospectively by clinical coordinators and
entered in the database by trained data-management
personnel. The study was undertaken after the approval
of the Ethics Committee (Comitato etico locale e comi-
tato etico per la sperimentazione clinica dei medicinali)
of Siena University Hospital. Due to the retrospective
nature of the study, the need for informed consent was
waived.
Blood transfusion was quantified as the number of
PRBC administered in the intensive care unit. The preo-
perative and intraoperative variables listed in Table 1
were considered a likely independent-variable set for
planning transfusion quantities in major heart surgery
procedures.
A set of postoperative variables (Table 2) was also
analysed for a clinical interpretation of model perfor-
mance. Morbidity outcome was associated with patients
developing at least one cardiovascular, respiratory, neu-
rological, renal, infectious or hemorrhagic complication
[12]. Mortality was defined as in-hospital death.
Clinical management
A broad-based blood conservation strategy was prac-
ticed in all patients, including:
￿ preoperative optimization of hemoglobin;
￿ intraoperative isovolemic hemodilution;
￿ autotransfusion;
￿ anemia tolerance (Hb < 7 g/dl);
￿ ultrafiltration during CPB for severe hemodilutional
anemia or diagnosis of renal failure;
￿ on-site coagulation monitoring (using thromboelas-
tography or activated clotting time);
￿ targeted pharmacotherapy (antifibrinolytic agents).
Patients were operated under moderate hypothermia
(34°C) and a-stat acid-base management. Roller or cen-
trifugal pumps were used with standard or biocompati-
ble circuits (heparin or phosphorylcholine treated) and
hollow-fibre oxygenators; the CPB circuit was primed
with crystalloid or colloid solutions at variable volumes
ranging from 900 to 1500 ml. Addition of PRBC to the
CPB machine prime was considered (though not routi-
nely given) if the calculated dilutional hematocrit was
less than 25%. Anticoagulation was established with
heparin to reach and maintain a target activated clotting
time of 480 s. In all patients, heparin was reversed by
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CPB. Pump flow was set between 2.0 and 2.8 l/(min
m
2), according to core temperature. During surgery with
conventional open CPB circuits, blood was taken from
the surgical field, collected in a reservoir, processed and
re-infused into the patient. After the operation and dur-
ing the first period of intensive care unit stay, mediast-
inal blood collected in a reservoir was not re-infused.
Although no rigid criterion or hemoglobin value was
adopted for transfusion, PRBC were not routinely con-
sidered until serum Hb was less than 7 g/dl, unless
there was evidence of ongoing blood loss or the patient
was clinically considered at risk of poor oxygenation.
This last determination included patients with signs of
poor tissue perfusion (lactate level < 2 mmol/l, mixed
venous oxygen saturation < 65%, urine output < 0.5 ml/
kg/h), significant hemodynamic instability requiring two
or more inotropic agents, utilization of intraaortic bal-
loon pump and multiple organ dysfunction. Fresh-frozen
plasma was used in cases of postoperative bleeding and
Table 1 Descriptive statistics of preoperative and intraoperative variables analyzed in the whole sample (3315
patients)
Variables Frequency count and percentage
Sex (female) 1093 (33.0%)
Age > 70 years 1549 (46.7%)
Body surface area > 1.8 m
2 1329 (40.1%)
Surgical procedure different from isolated coronary artery bypass graft 1559 (47.0%)
Previous cardiovascular surgery 147 (4.4%)
Emergency 67 (2.0%)
Non-routine procedure (urgency) 287 (8.7%)
Preoperative dialysis 21 (0.6%)
Systemic arterial hypertension 2227 (67.2%)
Diabetes requiring medical treatment 780 (23.5%)
Unstable angina 695 (21.0%)
Active endocarditis 16 (0.5%)
Recent myocardial infarction (< 7 days) 98 (3.0%)
Cardiogenic shock 32 (1.0%)
Chronic obstructive pulmonary disease 228 (6.9%)
Previous cerebrovascular events 165 (5.0%)
Admission hematocrit ≤ 40% 1973 (59.5%)
Antiplatelet therapy 1469 (44.3%)
Dicoumarole therapy 136 (4.1%)
Heparin therapy 1225 (37.0%)
Intraortic balloon pump insertion 83 (2.5%)
Serum creatinine > 1.2 mg/dl 599 (18.1%)
Cardiopulmonary bypass time > 130 minutes 1351 (40.8%)
Aortic clamping time > 90 minutes 1445 (43.6%)
Minimum hematocrit during cardiopulmonary bypass ≤ 20% 533 (16.1%)
Minimum temperature ≤ 32 °C 1639 (49.4%)
Table 2 Descriptive statistics of some essential
postoperative variables in the whole sample (3315
patients)
Variables Frequency count and percentage
Morbidity 1273 (38.4%)
Reoperation for bleeding 190 (5.7%)
Lung dysfunction 516 (15.6%)
Low cardiac output 442 (13.3%)
Cardiac arrhythmia 294 (8.9%)
Coma 35 (1.1%)
Stroke 33 (1.0%)
Acute kidney failure 71 (2.1%)
Kidney dysfunction 140 (4.2%)
Sepsis 26 (0.8%)
Pneumonia 51 (1.5%)
Sternal wound infection 17 (0.5%)
Death 58 (1.7%)
Mechanical ventilation > 1 day 422 (12.7%)
Intensive care > 5 days 391 (11.8%)
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Ratio > 1.5, i.e. thromboelastographic reaction time >
1.5 times the standard time). Platelet concentrates were
administered in cases of postoperative bleeding asso-
ciated with thromboelastographic maximal amplitude <
41 mm or low postoperative platelet count (< 50,000
cells/l).
Model design and validation
A linear regression model was designed to assess the
appropriate number of PRBC from training data. This
type of model is quite flexible and categorical variables
can be used as independent variables (regressors) with-
out much difficulty. The simplest and most common
way of creating variables to represent categories is
known as dummy variable analysis [13]. It enabled us
to divide patients into subgroups and to condense a
considerable amount of information in a single equation.
To design a dummy-variable linear-regression model,
it is necessary to create a series of binary (i.e. dummy)
variables that identify whether or not an observation
belongs to a specific category or group. Binary variables
can only be coded as one or zero. If an observation is
classified as a member of a particular category, then it is
coded one on the dummy variable representing that
category. Otherwise, the observation is coded zero. If a
model only contains dummy variables, it is equivalent to
analysis of variance. Regression with only dummy vari-
ables representing a single qualitative variable is equiva-
lent to one-way analysis of variance.
Our model to evaluate number of PRBC contained
only dummy regressors accounting for different catego-
rical variables. To do this, all continuous independent
variables were first dichotomized and then made binary
by selecting suitable cut-off points related to intensive
care unit morbidity [12], so that a dummy regressor was
set equal to zero if the corresponding categorical risk
factor was absent and to one if it was present. Since
patients with low risk factors received a number of
PRBC not significantly different from 0, a regression
without an intercept was used, thus assuming that
model output was zero when all dummy variables were
zero.
A stepwise procedure was used to select an optimal
subset of dummy regressors. Although stepwise methods
may overfit the data, they are usually employed to
reduce the number of potentially significant variables
and increase model generalization, i.e. the model’s ability
to maintain performance on cases not used for model
design. Stepwise regression is typically an automated
process of building a model by successively adding or
removing variables based solely on the F-statistics of
their estimated coefficients. At each step, the process
performs the following calculations: for each variable
currently in the model, it computes the F-statistic for its
estimated coefficient and reports this as its F-to-remove
statistic; for each variable not in the model, it computes
the F-statistic that its coefficient would have if it was
the next variable added and reports this as its F-to-enter
statistic. Then it enters the variable with the highest F-
to-enter statistic, or removes the variable with the lowest
F-to-remove statistic, according to specified control para-
meters. The process stops when no variable satisfies the
criteria for inclusion or removal. In the present paper
probability levels of 0.05 and 0.10 were set for F-to-enter
and F-to-remove statistics, respectively.
Once the regression model was obtained, the regres-
sion coefficients were rounded to the nearest half unit,
so that each dummy regressor equal to 1 simply corre-
sponded to an integer number of half PRBC. Of course,
for applicative purposes, the grand total of the model-
assessed half packs was then rounded to the next super-
ior integer of PRBC.
Model fit was evaluated by calculating the root mean
square error (RMSE) representing the average difference
between model-estimated and actual numbers of PRBC.
Since blood packs may sometimes be prescribed for
clinical situations not necessarily related to patient preo-
perative or intraoperative condition, or subjectively by
different operators, model accuracy was also evaluated,
analyzing in detail the clinical course of all patients in
cases where the absolute difference between the number
of packs transfused and the number estimated by the
model was greater than RMSE. This enabled remarkable
differences to be interpreted clinically and model restric-
tions to be made for proper application. In particular,
we divided model results into three categories: well
transfused patients, where the absolute value of the
model error was less than (or equal to) RMSE; less
transfused patients, where the difference between the
model estimate and the actual number of packs trans-
fused was greater than RMSE; over-transfused patients,
where the difference between the actual number of
packs transfused and the model estimate was greater
than RMSE.
The Mann-Whitney test was performed to compare
transfused quantities between normal and morbid
patients, considering actual and model-estimated num-
ber of PRBC. The Wilcoxon test for paired samples was
also used to test differences between actual and model-
estimated numbers of PRBC, taking normal and morbid
patient groups separately.
The statistical association between percentage morbid-
ity and the three groups of model agreement (or dis-
agreement) was evaluated applying the chi-square test to
contingency table. Pairwise group comparisons were also
carried out by the Fisher exact test for analysis of 2 × 2
subtables. Fisher exact test was also used to verify
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for model-selected dummy variables.
A p-value less than 0.05 was considered statistically
significant for all statistical tests. All computations were
done using SPSS and MATLAB code.
Results
Essential descriptive statistics of the sample are sum-
m a r i z e di nT a b l e s1 ,2a n d3 .P a t i e n t su n d e r w e n tt h e
following surgical procedures: 1756 (53%) isolated cor-
onary artery bypass graft surgery, 1006 (30%) single-
valve procedures (repair or replacement) and 553 (17%)
other types of procedures, primarily combined coronary
artery bypass graft surgery and valve surgery or aortic
surgery.
The overall mortality in the hospital was 1.7% and
postoperative complications (morbidity) were 38.4%. 190
patients (5.7%) required additional surgery for bleeding,
33 (1.0%) experienced permanent stroke according to
the classification of Ergin and colleagues [14] and 17
patients (0.5%) had sternal wound infection. Acute renal
failure requiring dialysis occurred in 71 patients (2.1%).
The duration of mechanical ventilation was 28.4 ± 97.7
hours and length of intensive care was 3.0 ± 5.4 days.
Chest tube drainage volume in 24 hours was 323 ± 328
ml.
2208 patients (67%) were transfused. 710 patients
(21%) received fresh frozen plasma, and 235 (7%)
received platelets. Some patients received more than
one type of blood product. Figure 1, showing percentage
morbidity against number of PRBC transfused, high-
lights a clear increase in percentage morbidity with
number of packs.
Table 4 shows the optimal subset of regressors
obtained step-by-step by the variable selection proce-
dure. Ten dummy variables were entered in the model
and none of them were removed. After rounding off
regression coefficients to the nearest half integer,
dummy regressors equal to one corresponded to an
integer number of half blood packs, as shown in the last
column of Table 4.
The RMSE on training data was less than three PRBC
(2.76 PRBC). Testing data gave a RMSE = 2.81 PRBC.
No statistical differences were found between training
and testing sets for all model selected dummy variables
(Fisher exact test, p > 0.05).
Comparing the actual numbers of packs transfused
with model-estimated numbers, the following three
groups of patients were defined on the basis of the esti-
mated RMSE value (about 2.8 PRBC):
-G r o u pI ,w h e r et h ed i f f e r e n c eb e t w e e nt h em o d e l
estimate and the actual number of packs transfused was
greater than two (patients in group I were named “less
transfused”, because they received appreciably fewer
transfusions than estimated by the model);
- Group II, where the absolute value of the difference
between the number of packs transfused and the num-
ber estimated by model was not more than two packs
("well transfused” patients);
- Group III, where the difference between the actual
number of packs transfused and the model estimate was
greater than two packs ("over transfused” patients).
Taken as a whole, we identified 303 (9.1%) less trans-
fused patients (151 in the training set and 152 the test-
ing set), 2574 (77.7%) well transfused patients (1278 and
1296, respectively) and 438 (13.2%) over transfused
patients (228 and 210, respectively). No statistical differ-
ences were found in the frequencies of groups I, II and
III between the training and testing sets (chi-square test,
p = 0.648), so all patients (in the training and testing
sets) were pooled for further analysis.
It can be underlined that the RMSE-based criterion
identified the group II of well transfused patients as
positively consistent with a clinically acceptable model
error. The percentage of over and less transfused
patients was 22.3%. The number of packs of red blood
cells was 0.53 ± 0.94, 1.7 ± 1.7 and 8.3 ± 4.7 for patients
of groups I, II and III, respectively.
Percentage morbidity was rather different in the three
groups. Group II showed the lowest morbidity (31.5%)
and group III the highest (71.0%). An intermediate value
(49.5%) was recorded in group I.
Figure 2 shows percentage morbidity against the dif-
ference between the actually transfused and model-esti-
mated number of PRBC. A negative (positive) difference
meant that the model estimated more (fewer) PRBC
Table 3 Patient numbers and related percentages by surgical procedure with respect to the whole sample of 3315
patients
Surgery procedure Patient number Transfused-patient number Mean value ± SD
of PRBC
CABG 1756 (53.0%) 1092 (62.3%) 2.0 ± 2.7
Valve 1006 (30.3%) 677 (67.3%) 2.6 ± 3.2
Other procedures 553 (16.7%) 439 (79.4%) 3.9 ± 3.5
The number and percentage of transfused patients are also reported for each surgical procedure together with the mean number and standard deviation of
PRBC.
PRBC = packs of red blood cells; SD = standard deviation; CABG = coronary artery bypass graft.
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and horizontal lines indicate the corresponding percen-
tage morbidity in the three groups. Figure 2 highlights
the remarkable increase in morbidity in less-transfused
and over-transfused patients. A clear positive relation-
ship is also evident between morbidity and difference
between model-estimated and actual number of packs
transfused. Percentage morbidity was about 28% in
patients for whom the model fitted the actual data
exactly, while the highest differences were associated
with very high morbidities. In particular, percentage
morbidity was about 65% with an absolute difference of
more than four PRBC in group I patients ("less trans-
fused”), and 88% with a difference of more than six
packs in group III ("over transfused”).
Statistical comparison of overall percentage morbid-
ities by the chi-square test and Fisher exact test revealed
significant differences between groups I, II and III. In
particular, percentage morbidity in group I was signifi-
cantly lower than in group III and higher than in group
II.
Statistically significant differences in number of packs
actually transfused were found between normal and
morbid patients (Mann-Whitney test). On average, the
number of packs transfused into morbid patients was
m o r et h a nt w i c et h a to fn o r m a lp a t i e n t s( 3 . 7±4 . 3v s .
1.7 ± 2.0 packs). The dummy-variable model estimated
that morbid patients needed significantly fewer packs
(2.7 ± 1.6 packs). For these patients the Wilcoxon test
for paired samples demonstrated significant differences
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Figure 1 Empirical distribution of percentage morbidity with respect to packs of red blood cells (PRBC) transfused.
Table 4 Stepwise procedure for dummy variable selection
Step no. Dummy variables Coefficients Estimated
PRBC
1 HctAdmission ≤ 40% 0.928 1
2 CBP time > 130 min 0.951 1
3 Minimum HctCBP ≤ 20% 2.000 2
4 Surgical procedure different from isolated CABG 0.936 1
5 Age > 70 years 0.616 0.5
6 Cardiogenic shock 2.627 2.5
7 Preoperative dialysis 4.246 4
8 Systemic arterial hypertension 0.384 0.5
9 Urgency 0.692 0.5
10 Emergency 1.390 1.5
Regression model coefficients are transformed into packs of red blood cells (PRBC) by rounding them to the nearest half integer.
Hct = hematocrit; CBP = cardiopulmonary bypass; CABG = coronary artery bypass graft.
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transfused.
Closer analysis of cases belonging to groups I and III
showed that:
- transfusion therapy not in line with our broad-based
blood conservation strategy was prescribed in about 60%
(182 out of 303) of patients in group I;
- about 82% (358 out of 438) of patients in group III
had occasional, unpredictable, adverse events deter-
m i n e dd i r e c t l yb ys u r g e r y ,s u c ha sb l e e d i n g ,b y - p a s s
graft occlusion, heart failure requiring mechanical sup-
port, infection, coma or acute kidney failure.
Table 5 summarizes the descriptive statistics of all
dichotomous predictors (preoperative and intraoperative
features) included in the model and some essential post-
operative variables for the three groups. The association
between each predictive or postoperative variable and
patient group was investigated analysing the correspond-
ing contingency table. The chi-square test for indepen-
dence showed statistically significant differences in all
circumstances, except urgency. Concentrating our atten-
tion on postoperative issues, this indicated a strong
association between the postoperative variables analysed
and the three groups.
Discussion
Heart surgery makes a large demand on available blood.
It has been estimated that 11% of blood resources are
used for transfusion support in patients undergoing
CABG [2] and nearly 20% of blood transfusions are
related to heart surgery [15]. Despite major advances in
perioperative blood conservation, the transfusion rate in
heart surgery patients remains high and large differences
can be observed in different centres [16]. In the present
study we found an overall transfusion percentage of
about 67%, only partially justified by the large number
of emergency and redo operations or high risk proce-
dures requiring prolonged CPB time.
Transfusion therapy, although recognised to be neces-
sary during heart surgery, may lead to an increased inci-
dence of complications. In fact, despite the difficulty of
separating the effects of transfusions from the underly-
ing severity of the clinical condition, several prior stu-
dies have demonstrated that allogeneic blood
transfusions are associated with an increased morbidity
rate (e.g. atrial fibrillation, renal dysfunction, pulmonary
complications and low cardiac output syndrome)
[17-20] and worse long-term survival [21]. Recently,
Koch and colleagues also showed that the length of sto-
rage of PRBC is associated with increased morbidity and
mortality in heart surgery and that transfusions with
blood stored for more than 14 days are associated with
a significantly increased in-hospital mortality rate [22].
This evidence has stimulated interest in developing dif-
ferent strategies of blood transfusion and conservation
in heart surgery and in identifying patients really requir-
ing transfusions during and/or after surgery.
Several authors analysed critical aspects of blood
transfusions in terms of morbidity and mortality and
used preoperative predictors for allogeneic transfusions
in order to develop a predictive transfusion risk score
for patients undergoing heart surgery [8,9,11]. Magovern
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Figure 2 Empirical distribution of percentage morbidity with respect to difference between actually transfused and model-estimated
numbers of packs of red blood cells (PRBC).
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isolated CABG procedures including emergency cases
and reoperations [8]. They observed that 61% received
transfusion during hospitalization, developing a model,
which predicted the need for transfusion after CABG,
based on 14 preoperative variables as predictors. Simi-
larly, Alghamdi and colleagues developed a model for
predicting the need for blood transfusion based on eight
preoperative variables [9]. Ranucci and colleagues devel-
oped a predictive score using five predictors extracted as
the most clinically relevant based on the judgement of
30 clinicians concerned with transfusions in heart sur-
gery [11]. Although built on a subjective choice of a few
predictors, the score seemed to have suitable predictive
power and calibration.
A general weakness of the above studies could be the
use of only preoperative predictors. Moskowitz and col-
leagues proposed six preoperative predictors and four
intraoperative predictors to create a formula to predict
transfusion requirements for major heart surgery proce-
dures in a centre that implements a multimodal
approach to blood conservation. However, they limited
Table 5 Descriptive statistics for all dichotomous (preoperative and intraoperative) predictors included in the model
and for some essential postoperative variables in three groups of patients: group I, where the difference between the
model estimate and the actual number of packs transfused was greater than two (303 patients); group II, where the
absolute value of the difference between the number of packs transfused and the number estimated by model was
not more than two packs (2574 patients); group III, where the difference between the actual number of packs
transfused and the model estimate was greater than two packs (438 patients)
Variables Frequency count and percentage in
group I
Frequency count and percentage in
group II
Frequency count and percentage in
group III
Preoperative and intraoperative predictors included in the model
Hctadmission ≤ 40% 257 (84.8%) 1450 (56.3%) 266 (60.7%)
CBP time > 130 min 222 (73.3%) 929 (36.1%) 200 (45.7%)
Minimum HctCBP ≤ 20% 108 (35.6%) 333 (12.9%) 92 (21.0%)
Surgical procedure
different
from isolated CABG
230 (75.9%) 1098 (42.7%) 231 (52.7%)
Age > 70 years 212 (70.0%) 1146 (44.5%) 241 (55.0%)
Cardiogenic shock 9 (29.0%) 17 (54.8%) 5 (16.1%)
Preoperative dialysis 7 (2.3%) 8 (0.3%) 6 (1.4%)
Systemic arterial
hypertension
243 (80.2%) 1701 (66.1%) 28 (64.6%)
Urgency 22 (7.3%) 220 (8.5%) 4 (10.3%)
Emergency 19 (6.3%) 37 (1.4%) 10 (2.3%)
Postoperative variables
Morbidity 150 (49.5%) 812 (31.5%) 311 (71.0%)
Reoperation for bleeding 14 (4.6%) 57 (2.2%) 118 (26.9%)
Lung dysfunction 58 (19.1%) 280 (10.9%) 178 (40.6%)
Low cardiac output 54 (17.8%) 239 (9.3%) 149 (34.0%)
Cardiac arrhythmia 37 (12.2%) 193 (7.5%) 64 (14.6%)
Coma 2 (0.7%) 15 (0.6%) 18 (4.1%)
Stroke 3 (1.0%) 19 (0.7%) 11 (2.5%)
Acute kidney failure 4 (1.3%) 26 (1.0%) 41 (9.4%)
Kidney dysfunction 16 (5.3%) 103 (4.0%) 21 (4.8%)
Sepsis 2 (0.7%) 7 (0.3%) 17 (3.8%)
Pneumonia 3 (1.0%) 17 (0.7%) 31 (7.8%)
Sternal wound infection 2 (0.7%) 7 (0.3%) 8 (1.8%)
Death 4 (1.3%) 26 (1.0%) 28 (6.4%)
Mechanical ventilation >
1 day
50 (16.5%) 206 (8.0%) 166 (37.9%)
Intensive care > 5 days 30 (5.2%) 135 (9.9%) 128 (29.2%)
Hct = hematocrit; CPB = cardiopulmonary bypass; CABG = coronary artery bypass graft.
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undergoing CABG, valve, and combined procedures
(CABC plus valve), where only 35 patients required
intraoperative or postoperative allogeneic transfusions.
In the present analysis, we selected a set of preopera-
tive and intraoperative variables statistically to develop a
dummy-variable linear-regression model using a sample
of 3315 consecutive heart surgery patients, where the
size of transfused and not-transfused samples was suffi-
ciently large. The role of dummies is to partition the
data set into groups based on qualitative criteria:
researchers in economics and the social sciences make
wide use of linear regression models in which the
dependent variable is continuous-valued while the
regressors are dummy variables. Despite its recognized
capabilities, this approach is not yet extensively used in
medical studies and to our knowledge, no model for
predicting the need for transfusions in heart surgery
patients has been developed by this method.
The present model selected eight preoperative and
two intraoperative dummy regressors, which in our
experience are associated with need for blood transfu-
sion (admission hematocrit ≤ 40%, CPB > 130 minutes,
hematocrit at CBP ≤ 20%, operation different from iso-
lated CABG, age > 70 years, cardiogenic shock, preo-
perative dialysis, systemic arterial hypertension, urgent
and emergency operation). Approximating the regres-
sion coefficients to the nearest half unit, each dummy
variable equal to 1 gave an integer number of half
PRBC. Thus the model enabled prompt and simple
planning of transfusions needs, patient-by-patient.
Most of the above variables were identified as impor-
tant transfusion predictors in other studies. Hardy
reported that the risk of exposure to blood transfusion
increased in patients undergoing combined cardiac or
valve procedures and that urgent surgery was a key
independent predictor of exposure to blood transfusion
[23]. In a systematic review study, different variables
w e r ef o u n dt ob ea s s o c i a t e dw i t hi n c r e a s e dr e dc e l l
transfusion rates: these included renal insufficiency,
urgent/emergency surgery, low hematocrit and older age
[24]. In particular, a decline in kidney function (insuffi-
ciency or failure) was associated with significantly
increased transfusion rates, because the odds of transfu-
sion increased 1.5- to 8-fold. Similarly, urgent or emer-
gency surgery was identified as a very important risk
factor associated with a 4- to 8-fold increase in transfu-
sion rates compared to elective surgery. The conclusion
was that transfusion practices for adults having emer-
gency or urgent surgery need to be optimized because
o ft h ee f f e c to fu s u a l l yp r e s c r i b e da n t i c o a g u l a n ta n d
antiplatelet agents on blood loss. The report from the
STS Workforce on Evidence Based Surgery indicates
that numerous studies have identified prolonged CPB
time as a risk factor associated with increased transfu-
sions [2], in line with increased blood cell damage and
coagulation disorders due to alteration of the coagula-
tion cascade [25]. Swaminathan and colleagues found an
association between lowest hematocrit during CPB and
increased transfusion [26], while Takami and Masumoto
recently indicated that independent factors for allo-
geneic blood transfusion included preoperative and
minimum hemoglobin values during cardiopulmonary
bypass [27]. The association between low preoperative
hematocrit and increased transfusion is generally con-
firmed by several studies [2].
The use of dummy variables in linear regression mod-
els is very useful when the data set has to be partitioned
into groups based on qualitative criteria, but the inclu-
sion of dummies tends to degrade the robustness of lin-
ear regression estimators when the sample contains
anomalous observations. In the present paper we criti-
cally reviewed the transfusion strategy of all patients to
test the model from a clinical point of view. In particu-
lar, we identified three groups of patients analyzing the
difference between the model-estimated and actual
number of packs transfused. On the basis of the model
RMSE we defined a group of “less transfused” patients
(Group I, 9.1%) who received appreciably fewer packs
than estimated by the model. Similarly, the group of
“over-transfused” patients (Group III, 13.2%) included
all patients who received appreciably more blood packs
than estimated by the model. Of course, the group II
contained the majority patients (77.7%) who showed less
difference between estimated and actual number of
packs. A posteriori analysis showed that during surgery,
about 82% of patients in group III had an unforeseeable
adverse event such as bleeding, by-pass graft occlusion,
heart failure requiring mechanical support, infection,
coma or acute kidney failure, while about 60% of
patients in group I received transfusion therapy at var-
iance with our broad-based blood conservation strategy.
When these patients were removed from the sample,
the percentage of cases in which the model estimate and
the actual number of packs transfused differed by more
than two packs, decreased to only 7%. This suggests
that model outcome is clinically reliable and model
errors are sufficiently small.
We found significantly higher morbidity in patients of
groups I and III. Surprisingly, a posteriori analysis of
EUROSCORE (not reported in Results), did not reveal
a n yd i f f e r e n c ei nE U R O S C O R E[ 2 8 ]b e t w e e nt h et h r e e
groups. It is interesting that the increase in morbidity
was much more evident in group III where it reached
71.0% against 31.5% in group II. In line with several pre-
vious studies, this seems to suggest that “unnecessary”
transfusions may be associated with an increase in com-
plications. Although the model estimated less need for
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capability in these critical cases needs to be evaluated in
more detail. The present retrospective analysis did not
allow us to clarify this controversial matter once and for
all. The problem could perhaps be better analysed by a
further prospective study, comparing outcomes in ran-
domized trials. However, this is a not simple point,
because instead of causing complications, transfusions
are often given when there are heart surgery complica-
tions and this association may reflect a tendency to
transfuse critically ill patients. In any case, the model is
an aid to clinical decision making, providing quantitative
information and alerting medical teams to reconsider
decisions diverging radically from model prediction.
The present model does not predict unforeseeable
adverse events during surgery and therefore cannot fore-
cast the actual need for transfusion in patients with such
problems. However, it can be a useful auxiliary to plan
transfusion needs ap r i o r iin most situations, enabling a
reduction in healthcare costs.
In short, our study underlines the need for standardi-
zation in transfusion practices and suggests a very sim-
ple transfusion model that can facilitate optimization of
administration of blood products.
Conclusions
Unnecessary blood transfusions during heart surgery
increase healthcare costs directly, because blood is an
increasingly scarce and expensive resource, and indir-
ectly, due to complications associated with transfusions.
Clinical use of a simple and reliable transfusion model
can improve conservation strategy and optimize admin-
istration of blood products.
In the patient sample studied, a dummy-variable lin-
ear-regression model proved to be a convenient tool for
predicting transfusion needs ap r i o r iin most heart sur-
gery situations on the basis of some preoperative and
intraoperative information. Clinical use of this type of
model is extremely simple and immediate, since each
dummy predictor equal to one directly indicates an esti-
mated number of blood packs.
In conclusion, although further validation is necessary,
t h er e s u l t sc l e a r l yi n d i c a t et h a tt h ep r e s e n tm o d e l l i n g
approach enables design of a useful decision system for
planning transfusion needs in patients after heart
surgery.
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